BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19995674)

  • 1. P2'-truncated BACE-1 inhibitors with a novel hydroxethylene-like core.
    Meredith JA; Björklund C; Adolfsson H; Jansson K; Hallberg A; Rosenquist A; Samuelsson B
    Eur J Med Chem; 2010 Feb; 45(2):542-54. PubMed ID: 19995674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of potent and selective BACE-1 inhibitors.
    Björklund C; Oscarson S; Benkestock K; Borkakoti N; Jansson K; Lindberg J; Vrang L; Hallberg A; Rosenquist A; Samuelsson B
    J Med Chem; 2010 Feb; 53(4):1458-64. PubMed ID: 20128595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of hydroxyethylene-based peptidomimetic inhibitors of human beta-secretase.
    Hom RK; Gailunas AF; Mamo S; Fang LY; Tung JS; Walker DE; Davis D; Thorsett ED; Jewett NE; Moon JB; John V
    J Med Chem; 2004 Jan; 47(1):158-64. PubMed ID: 14695829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of potent BACE-1 inhibitors incorporating a hydroxyethylene isostere as central core.
    Wångsell F; Gustafsson K; Kvarnström I; Borkakoti N; Edlund M; Jansson K; Lindberg J; Hallberg A; Rosenquist A; Samuelsson B
    Eur J Med Chem; 2010 Mar; 45(3):870-82. PubMed ID: 20036448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of potent BACE-1 inhibitors containing a new hydroxyethylene (HE) scaffold: exploration of P1' alkoxy residues and an aminoethylene (AE) central core.
    Björklund C; Adolfsson H; Jansson K; Lindberg J; Vrang L; Hallberg A; Rosenquist S; Samuelsson B
    Bioorg Med Chem; 2010 Feb; 18(4):1711-23. PubMed ID: 20122837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminoethylenes: a tetrahedral intermediate isostere yielding potent inhibitors of the aspartyl protease BACE-1.
    Yang W; Lu W; Lu Y; Zhong M; Sun J; Thomas AE; Wilkinson JM; Fucini RV; Lam M; Randal M; Shi XP; Jacobs JW; McDowell RS; Gordon EM; Ballinger MD
    J Med Chem; 2006 Feb; 49(3):839-42. PubMed ID: 16451048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and SAR of potent statine-based BACE-1 inhibitors: exploration of P1 phenoxy and benzyloxy residues.
    Bäck M; Nyhlén J; Kvarnström I; Appelgren S; Borkakoti N; Jansson K; Lindberg J; Nyström S; Hallberg A; Rosenquist S; Samuelsson B
    Bioorg Med Chem; 2008 Nov; 16(21):9471-86. PubMed ID: 18842420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and SAR of macrocyclic tertiary carbinamine BACE-1 inhibitors.
    Lindsley SR; Moore KP; Rajapakse HA; Selnick HG; Young MB; Zhu H; Munshi S; Kuo L; McGaughey GB; Colussi D; Crouthamel MC; Lai MT; Pietrak B; Price EA; Sankaranarayanan S; Simon AJ; Seabrook GR; Hazuda DJ; Pudvah NT; Hochman JH; Graham SL; Vacca JP; Nantermet PG
    Bioorg Med Chem Lett; 2007 Jul; 17(14):4057-61. PubMed ID: 17482814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and evaluation of Leu*Ala hydroxyethylene-based non-peptide beta-secretase (BACE) inhibitors.
    Xiao K; Li X; Li J; Ma L; Hu B; Yu H; Fu Y; Wang R; Ma Z; Qiu B; Li J; Hu D; Wang X; Shen J
    Bioorg Med Chem; 2006 Jul; 14(13):4535-51. PubMed ID: 16510290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of BACE-1 inhibitors utilizing a tertiary hydroxyl motif as the transition state mimic.
    Wångsell F; Russo F; Sävmarker J; Rosenquist A; Samuelsson B; Larhed M
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4711-4. PubMed ID: 19576765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent pyrrolidine- and piperidine-based BACE-1 inhibitors.
    Iserloh U; Wu Y; Cumming JN; Pan J; Wang LY; Stamford AW; Kennedy ME; Kuvelkar R; Chen X; Parker EM; Strickland C; Voigt J
    Bioorg Med Chem Lett; 2008 Jan; 18(1):414-7. PubMed ID: 18023580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of hydroxyethylamine (HEA) BACE-1 inhibitors: structure-activity relationship of the aryl region.
    Probst GD; Bowers S; Sealy JM; Stupi B; Dressen D; Jagodzinska BM; Aquino J; Gailunas A; Truong AP; Tso L; Xu YZ; Hom RK; John V; Tung JS; Pleiss MA; Tucker JA; Konradi AW; Sham HL; Jagodzinski J; Toth G; Brecht E; Yao N; Pan H; Lin M; Artis DR; Ruslim L; Bova MP; Sinha S; Yednock TA; Gauby S; Zmolek W; Quinn KP; Sauer JM
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6034-9. PubMed ID: 20822903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving the permeability of the hydroxyethylamine BACE-1 inhibitors: structure-activity relationship of P2' substituents.
    Truong AP; Probst GD; Aquino J; Fang L; Brogley L; Sealy JM; Hom RK; Tucker JA; John V; Tung JS; Pleiss MA; Konradi AW; Sham HL; Dappen MS; Tóth G; Yao N; Brecht E; Pan H; Artis DR; Ruslim L; Bova MP; Sinha S; Yednock TA; Zmolek W; Quinn KP; Sauer JM
    Bioorg Med Chem Lett; 2010 Aug; 20(16):4789-94. PubMed ID: 20634069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitor binding to the plasmepsin IV aspartic protease from Plasmodium falciparum.
    Gutiérrez-de-Terán H; Nervall M; Ersmark K; Liu P; Janka LK; Dunn B; Hallberg A; Aqvist J
    Biochemistry; 2006 Sep; 45(35):10529-41. PubMed ID: 16939205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the catalytic aspartates.
    Bowers S; Xu YZ; Yuan S; Probst GD; Hom RK; Chan W; Konradi AW; Sham HL; Zhu YL; Beroza P; Pan H; Brecht E; Yao N; Lougheed J; Tam D; Ren Z; Ruslim L; Bova MP; Artis DR
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2181-6. PubMed ID: 23465612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, SAR, and X-ray structure of human BACE-1 inhibitors with cyclic urea derivatives.
    Park H; Min K; Kwak HS; Koo KD; Lim D; Seo SW; Choi JU; Platt B; Choi DY
    Bioorg Med Chem Lett; 2008 May; 18(9):2900-4. PubMed ID: 18434152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of 2,3,5-substituted imidazolidin-4-one inhibitors of BACE-1.
    Barrow JC; Rittle KE; Ngo PL; Selnick HG; Graham SL; Pitzenberger SM; McGaughey GB; Colussi D; Lai MT; Huang Q; Tugusheva K; Espeseth AS; Simon AJ; Munshi SK; Vacca JP
    ChemMedChem; 2007 Jul; 2(7):995-9. PubMed ID: 17458843
    [No Abstract]   [Full Text] [Related]  

  • 18. Structure-based design and synthesis of macrocyclic peptidomimetic beta-secretase (BACE-1) inhibitors.
    Machauer R; Veenstra S; Rondeau JM; Tintelnot-Blomley M; Betschart C; Neumann U; Paganetti P
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1361-5. PubMed ID: 19195886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrocyclic BACE inhibitors: Optimization of a micromolar hit to nanomolar leads.
    Huang Y; Strobel ED; Ho CY; Reynolds CH; Conway KA; Piesvaux JA; Brenneman DE; Yohrling GJ; Moore Arnold H; Rosenthal D; Alexander RS; Tounge BA; Mercken M; Vandermeeren M; Parker MH; Reitz AB; Baxter EW
    Bioorg Med Chem Lett; 2010 May; 20(10):3158-60. PubMed ID: 20399652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and preliminary evaluation of peptidomimetic inhibitors of human beta-secretase.
    Niu Y; Wang Y; Zou X; Yang X; Ma C; Lü Y; Zhou B; Yuan Y; Du G; Xu P
    Eur J Med Chem; 2010 May; 45(5):2089-94. PubMed ID: 20153560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.